Suchergebnisse - "Gaskell, Charlotte"

PubPharm (11)

1

Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

enthalten in: bioRxiv.org | 2024

von Fisher, B. | Veenith, T. | Slade, D. | +21

2

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT) : study protocol for a multi-centre, open-label, randomised, phase II platform trial

enthalten in: BMC cancer | 2024

von McIlroy, G. | Lax, S. | Gaskell, C. | +12

3

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial

enthalten in: BMC cancer | 2024

von McIlroy, G. | Lax, S. | Gaskell, C. | +12

4

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS) : an open-label, multicentre, phase II trial in four histological strata

enthalten in: British journal of cancer | 2023

von Woll, P. | Gaunt, P. | Gaskell, C. | +12

5

Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes

enthalten in: British journal of haematology | 2023

von Loke, J. | Upasani, V. | Gaskell, C. | +31

6

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

enthalten in: Nature medicine | 2023

von Barnes, E. | Goodyear, C. | Willicombe, M. | +146

7

Defective T‐cell response to COVID‐19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes

enthalten in: British Journal of Haematology | 2023

von Loke, J. | Upasani, V. | Gaskell, C. | +31

8

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

enthalten in: ResearchSquare.com | 2022

von Pascoe, J. | Houlton, A. | Gaskell, C. | +4

9

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST) : a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Fisher, B. | Veenith, T. | Slade, D. | +56

10

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer : an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

enthalten in: BMC cancer | 2021

von Pascoe, J. | Jackson, A. | Gaskell, C. | +4